Call Text Chat Email Refer a Patient Join a Study

Search

MotherToBaby

Medications and More during pregnancy and breastfeeding

Alirocumab (Praluent®)

Selected References:

  • Anderson PO. 2021. Monoclonal antibodies during breastfeeding. Breastfeeding Medicine. 16(8): 591-93. 
  • Noseda R, et al. 2024. Safety of Monoclonal Antibodies Inhibiting PCSK9 in Pregnancy: Disproportionality Analysis in VigiBase®. Clin Pharmacol Ther. 116(2)346-350. 
  • Praluent® Prescribing Information. Available online at: https://www.regeneron.com/downloads/praluent_pi.pdf. Accessed April 1, 2026 
  • Vuignier Y, et al. 2021. Exposure to alirocumab during the first trimester of pregnancy: A case report. Birth Defects Research. 113(15): 1156–60.  

 

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $1,200,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.